Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence AEDHFSVIDFNQNIR
Primary information
sequence IDSeq_216
Peptide sequenceAEDHFSVIDFNQNIR
CancerPDF_ID CancerPDF_ID766, CancerPDF_ID819, CancerPDF_ID1792,
PMID19795908,19795908,21136997
Protein NameInter-alpha-trypsin inhibitor heavy chain H2,Inter-alpha-trypsin inhibitor heavy chain H2,Inter-alpha-trypsin inhibitor heavy chain H2
UniprotKB Entry NameITIH2_HUMAN,ITIH4_HUMAN,ITIH2_HUMAN
FluidPlasma,Plasma,Serum
M/Z602.28,602.28,1803.85401
Charge3,2,1
Mass (in Da)NA,NA,NA
fdrNA,NA,NA
Profiling TechniqueLC-MS,LC-MS,LC-MS
Peptide Identification techniqueMALDI-TOF/TOF,MALDI-TOF/TOF,LC-MS-MS/MS
Quantification TechniqueLC-MRM (multiple reaction monitoring),LC-MRM (multiple reaction monitoring),LC-ESI-MS
Labelled/Label FreeLabelled,Labelled,Label Free
FDRless than 7%,less than 7%,NA
CancerPDF_ID CancerPDF_ID766, CancerPDF_ID819, CancerPDF_ID1792,
p-ValueNA,NA,NA
SoftwareFlexAnalysis 3.0 and Biotools 3.0 software,FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01)
Length15,15,15
Cancer TypeDuctal adenocarcinoma of the pancreas (DAP),Ductal adenocarcinoma of the pancreas (DAP),Colorectal cancer
DatabaseNCBI refseq Protein Database,NCBI refseq Protein Database,SwissProt Database
ModificationNA,NA,NA
Number of Patients"41 normal, 23 patients","42 normal, 23 patients",30 patients and 30 healthy controls
RegulationNA,NA,NA
ValidationNA,NA,Leave One out Cross validation
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasPeptideAtlas
IEDB